Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Warach

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Stroke|April 1, 2006
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onsetAnthony J Furlan, Dirk Eyding, Gregory W Albers, et al.
Trauma Surgery & Acute Care Open|December 14, 2020
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trialsBen King, Truman Milling, Byron Gajewski, et al.
Stroke|June 29, 2012
Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trialsSteven Warach, Yasir Al-Rawi, Anthony J Furlan, et al.
Lancet (London, England)|January 30, 2007
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparisonJulio A Chalela, Chelsea S Kidwell, Lauren M Nentwich, et al.
Stroke|April 11, 2013
Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarctionJason W Freeman, Marie Luby, José G Merino, et al.
Stroke|December 1, 2004
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplaseWerner Hacke, Greg Albers, Yasir Al-Rawi, et al.
Digital Health|October 9, 2024
Stroke survivors' telemedicine experiences during the COVID-19 pandemic: A phenomenological investigationBarbara Kimmel, Annette Walder, Anette Ovalle, et al.
The Lancet. Neurology|January 24, 2009
Cerebral microbleeds: a guide to detection and interpretationSteven M Greenberg, Meike W Vernooij, Charlotte Cordonnier, et al.
Biological Research for Nursing|August 16, 2014
A genomic profile of the immune response to stroke with implications for stroke recoveryTaura L Barr, Reyna VanGilder, Stephanie Rellick, et al.
Magnetic Resonance Imaging|April 17, 2013
Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging featuresFabien Scalzo, Jeffry R Alger, Xiao Hu, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Stroke|April 1, 2006
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onsetAnthony J Furlan, Dirk Eyding, Gregory W Albers, et al.
Trauma Surgery & Acute Care Open|December 14, 2020
Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trialsBen King, Truman Milling, Byron Gajewski, et al.
Stroke|June 29, 2012
Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trialsSteven Warach, Yasir Al-Rawi, Anthony J Furlan, et al.
Lancet (London, England)|January 30, 2007
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparisonJulio A Chalela, Chelsea S Kidwell, Lauren M Nentwich, et al.
Stroke|April 11, 2013
Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarctionJason W Freeman, Marie Luby, José G Merino, et al.
Stroke|December 1, 2004
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplaseWerner Hacke, Greg Albers, Yasir Al-Rawi, et al.
Digital Health|October 9, 2024
Stroke survivors' telemedicine experiences during the COVID-19 pandemic: A phenomenological investigationBarbara Kimmel, Annette Walder, Anette Ovalle, et al.
The Lancet. Neurology|January 24, 2009
Cerebral microbleeds: a guide to detection and interpretationSteven M Greenberg, Meike W Vernooij, Charlotte Cordonnier, et al.
Biological Research for Nursing|August 16, 2014
A genomic profile of the immune response to stroke with implications for stroke recoveryTaura L Barr, Reyna VanGilder, Stephanie Rellick, et al.
Magnetic Resonance Imaging|April 17, 2013
Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging featuresFabien Scalzo, Jeffry R Alger, Xiao Hu, et al.
Pageof 15